Zetagen Therapeutics, Inc.

Pharmaceutical company · Syracuse, New York, United States

Zetagen Therapeutics, Inc. is a pharmaceutical company headquartered in Syracuse, New York, United States. Its earliest recorded incorporation is in 2015. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $2.8 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2025.

www.zetagen.comProfile compiled from public records. Is this your company? Request a correction or update

Zetagen Therapeutics at a glance

Typepharmaceutical company
HeadquartersSyracuse, New York, United States
Earliest incorporation on record2015
Employees (per SBIR records)5
SEC CIK1730728

What does Zetagen Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $2.8 million in total (2018 to 2021). NIH funding came from the National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $12.9 million sold (2025).

Frequently asked questions about Zetagen Therapeutics

Where is Zetagen Therapeutics headquartered?

Zetagen Therapeutics, Inc. is headquartered in Syracuse, New York, United States.

What does Zetagen Therapeutics do?

Zetagen Therapeutics, Inc. is a pharmaceutical company.

When was Zetagen Therapeutics founded?

The earliest incorporation on record for Zetagen Therapeutics, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.